• CHICAGO & CAMBRIDGE, Mass .– (BUSINESS WIRE) – Exicure, Inc. (Nasdaq: XCUR), a pioneer of gene regulation and immunotherapeutic drugs using spherical nucleic acid (SNA ™) constructs, today announced that it has entered into a senior secured term loan of $ 25.0 million with MidCap Financial Trust (MidCap), as agent, and Silicon Valley Bank (SVB).

    Read more